Merck said on Tuesday it would not ship its ... Pfizer's bladder cancer therapy meets main goal in late-stage study Reuters, the news and media division of Thomson Reuters, is the world’s ...
As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
SpringWorks Therapeutics shares rose 36% after Reuters reported Germany's Merck KGaA is in advanced talks to buy the company. Shares were trading around $54.66. The stock is up 16% over the last year ...
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback